Alumis Alternatives & Competitors
12 companies similar to Alumis — Transforming the lives of patients living with immune-mediated diseases using a...
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new trea...
Agoura Hills, United Stat...
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Capstan Therapeutics
Advancing cell engineering to develop therapeutics for a broad range of diseases
Celsius Therapeutics
On a quest to leverage the power of single cell genomics to discover novel drug targets an...
Cambridge, United States
Track all Alumis competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Ocugen
Approaching healthcare innovation with purpose and agility to deliver new breakthroughs fo...
Malvern, United States
Retex Pharmaceuticals
Watertown, United States
Matchpoint Therapeutics
Acing the future of covalent medicines
Mozart Therapeutics, Inc.
Orchestrating the Immune System
Seattle, United States
DeepCure
Reimagining small molecule therapies for immune diseases
Boston, United States
Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune dis...
Arbor Biotechnologies
Genetic medicines for genetic diseases
Cambridge, United States
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine lea...
Cambridge, United States
About Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision approach.
Development of targeted therapies, Clinical trial management, Proprietary data analytics for precision medicine, Patient resources and expanded access policy
Patients with immune-mediated diseases, Healthcare providers, Medical researchers, Investors in biotech and pharmaceutical sectors
Immune-mediated Diseases, Precision Medicine, Targeted Therapies, Drug Development, Autoimmune Diseases, Immunology, Pharmaceuticals, Integrated Therapy Development, Immunosuppression Alternatives, Patient-centric Solutions, Disease-specific Drug Targeting, Therapeutic Innovation, Healthcare Analytics
B2B, D2C, B2D
Product Sales, Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Alumis and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Alumis on 9 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.